| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.38 | 5e-13 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.31 | 7e-12 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.29 | 3e-10 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.27 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |